Targeting Hedgehog Signalling Through the Ubiquitylation Process: The Multiple Roles of the HECT-E3 Ligase Itch
Overview
Biophysics
Cell Biology
Molecular Biology
Authors
Affiliations
Hedgehog signalling (Hh) is a developmental conserved pathway strongly involved in cancers when deregulated. This important pathway is orchestrated by numerous regulators, transduces through distinct routes and is finely tuned at multiple levels. In this regard, ubiquitylation processes stand as essential for controlling Hh pathway output. Although this post-translational modification governs proteins turnover, it is also implicated in non-proteolytic events, thereby regulating the most important cellular functions. The HECT E3 ligase Itch, well known to control immune response, is emerging to have a pivotal role in tumorigenesis. By illustrating Itch specificities on Hh signalling key components, here we review the role of this HECT E3 ubiquitin ligase in suppressing Hh-dependent tumours and explore its potential as promising target for innovative therapeutic approaches.
SMURF1 and SMURF2 directly target GLI1 for ubiquitination and proteasome-dependent degradation.
Bordin F, Terriaca G, Apostolico A, Di Fiore A, Mir F, Bellardinelli S Cell Death Discov. 2024; 10(1):498.
PMID: 39695131 PMC: 11655642. DOI: 10.1038/s41420-024-02260-4.
A targeted multi-proteomics approach generates a blueprint of the ciliary ubiquitinome.
Aslanyan M, Doornbos C, Diwan G, Anvarian Z, Beyer T, Junger K Front Cell Dev Biol. 2023; 11:1113656.
PMID: 36776558 PMC: 9908615. DOI: 10.3389/fcell.2023.1113656.
The regulatory roles of the E3 ubiquitin ligase NEDD4 family in DNA damage response.
Lu X, Xu H, Xu J, Lu S, You S, Huang X Front Physiol. 2022; 13:968927.
PMID: 36091384 PMC: 9458852. DOI: 10.3389/fphys.2022.968927.
The Roles of NEDD4 Subfamily of HECT E3 Ubiquitin Ligases in Neurodevelopment and Neurodegeneration.
Haouari S, Vourch P, Jeanne M, Marouillat S, Veyrat-Durebex C, Lanznaster D Int J Mol Sci. 2022; 23(7).
PMID: 35409239 PMC: 8999422. DOI: 10.3390/ijms23073882.
Proteolysis-Targeting Chimera (PROTAC): Is the Technology Looking at the Treatment of Brain Tumors?.
Lospinoso Severini L, Bufalieri F, Infante P, Di Marcotullio L Front Cell Dev Biol. 2022; 10:854352.
PMID: 35242765 PMC: 8886235. DOI: 10.3389/fcell.2022.854352.